Clinical Trial Update: The Effects of Rasagiline on Cognitive Deficits Associated With Parkinson's Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effects of rasagiline on cognitive deficits in Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Azilect (rasagiline)

Snippet

Sponsor: Istanbul University | Conditions: Parkinson's Disease | Phase 4 | Status: UNKNOWN